ProPhase Labs, Inc.
PRPH
$0.02
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -18.93% | -66.60% | -47.52% | -37.64% | -17.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.93% | -66.60% | -47.52% | -37.64% | -17.09% |
| Cost of Revenue | 53.02% | -65.64% | -67.34% | -16.24% | -69.08% |
| Gross Profit | -69.21% | -68.25% | 264.67% | -157.21% | 573.55% |
| SG&A Expenses | -37.91% | -32.26% | -65.03% | -29.48% | -33.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.89% | -39.48% | -65.34% | -28.48% | -41.12% |
| Operating Income | 32.07% | 28.88% | 66.88% | 26.48% | 46.13% |
| Income Before Tax | 17.71% | 14.92% | 57.83% | 6.38% | 52.35% |
| Income Tax Expenses | -98.46% | -- | -104.27% | 93.74% | 134.06% |
| Earnings from Continuing Operations | 31.78% | -14.45% | 77.96% | -37.74% | 18.14% |
| Earnings from Discontinued Operations | -- | -- | 100.00% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.78% | -235.00% | 78.47% | -3.83% | 27.32% |
| EBIT | 32.07% | 28.88% | 66.88% | 26.48% | 46.13% |
| EBITDA | 33.91% | 24.67% | 69.79% | 24.83% | 55.29% |
| EPS Basic | 79.78% | -138.62% | 97.67% | 52.32% | 66.95% |
| Normalized Basic EPS | 60.55% | 75.02% | 94.62% | 55.65% | 84.85% |
| EPS Diluted | 79.63% | -138.69% | 97.67% | 52.32% | 66.92% |
| Normalized Diluted EPS | 60.55% | 75.02% | 94.62% | 55.65% | 84.85% |
| Average Basic Shares Outstanding | 237.41% | 249.62% | 822.17% | 117.73% | 119.93% |
| Average Diluted Shares Outstanding | 237.41% | 249.62% | 822.17% | 117.73% | 119.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |